MPAR
Live / Registered — Registered (as of 16 May 2023)
What this means for you
Registered since 16 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88126025
- Registration number
- 7055521
- Mark type
- Stylized text
- Filed
- 20 Sept 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 16 May 2023
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, drug precursors, administered in a variety of forms and through various routes, that function as drug delivery agents to provide controlled release of active ingredients for a wide variety of pharmaceuticals, resulting in benefits such as a modified PK profile, tamper resistance, abuse resistance and overdose protection
Owner
- Ensysce Biosciences, Inc., La Jolla, CA, US
- Ensysce Biosciences, Inc., La Jolla, CA, US
- Ensysce Biosciences, Inc., La Jolla, CA, US
Prosecution history
- 16 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 30 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Oct 2022 — NON-FINAL ACTION E-MAILED
- 12 Oct 2022 — SU - NON-FINAL ACTION - WRITTEN
- 07 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Oct 2022 — USE AMENDMENT FILED
- 03 Oct 2022 — TEAS STATEMENT OF USE RECEIVED
- 24 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Mar 2022 — SOU EXTENSION 5 GRANTED